Growth Metrics

Enhabit (EHAB) Receivables Refunds (2022 - 2023)

Enhabit recorded quarterly Receivables Refunds of $3.0 million in Q4 2023, up 11.11% quarter-over-quarter from $2.7 million in Q3 2023, and down 73.68% year-over-year from $11.4 million in Q4 2022.

Enhabit's Receivables Refunds history runs 2 years deep, the most recent figure standing at $3.0 million for Q4 2023.

  • In Q4 2023, Receivables Refunds fell 73.68% year-over-year to $3.0 million; the TTM figure through Dec 2023 stood at $3.0 million (down 73.68% YoY), while the FY2023 annual figure was $3.0 million, down 73.68% from the prior year.
  • Receivables Refunds came in at $3.0 million for Q4 2023 at Enhabit, up from $2.7 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $11.4 million in Q4 2022 to a low of $2.7 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 35.78 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 146.90 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Enhabit 706.56 Mn 680.46 Mn 130.60 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 3.00 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 3.90 Mn
Mar 31, 2023 4.30 Mn
Dec 31, 2022 11.40 Mn
Sep 30, 2022 7.90 Mn